| MEF2B |
Q02080
|
myocyte enhancer factor 2B
|
|
9.3E-04 |
0.670 |
0.308 |
| GCSAM |
Q8N6F7
|
germinal center associated signaling and motility
|
|
6.4E-02 |
0.705 |
0.346 |
| NFKBIE |
O00221
|
NFKB inhibitor epsilon
|
|
0.77 |
0.700 |
0.385 |
| P2RY8 |
Q86VZ1
|
P2Y receptor family member 8
|
G-protein coupled receptor
|
3.4E-03 |
0.700 |
0.385 |
| PATZ1 |
Q9HBE1
|
POZ/BTB and AT hook containing zinc finger 1
|
|
1.00 |
0.647 |
0.423 |
| TCL1A |
P56279
|
T cell leukemia/lymphoma 1A
|
|
5.7E-10 |
0.558 |
0.500 |
| TCL1B |
O95988
|
T cell leukemia/lymphoma 1B
|
|
1.0E-02 |
0.561 |
0.500 |
| CD244 |
Q9BZW8
|
CD244 molecule
|
|
5.7E-02 |
0.653 |
0.500 |
| MIR618 |
|
microRNA 618
|
|
|
0.670 |
0.500 |
| BCL2L2-PABPN1 |
Q92843
|
BCL2L2-PABPN1 readthrough
|
|
0.28 |
0.653 |
0.500 |
| SUZ12 |
Q15022
|
SUZ12 polycomb repressive complex 2 subunit
|
Nucleic acid binding
|
1.00 |
0.529 |
0.577 |
| BTLA |
Q7Z6A9
|
B and T lymphocyte associated
|
|
2.1E-02 |
0.593 |
0.577 |
| BCL2L2 |
Q92843
|
BCL2 like 2
|
Signaling
|
0.47 |
0.599 |
0.615 |
| NPR2 |
P20594
|
natriuretic peptide receptor 2
|
Kinase
|
4.2E-05 |
0.573 |
0.615 |
| PTPRJ |
Q12913
|
protein tyrosine phosphatase receptor type J
|
Enzyme
|
1.3E-11 |
0.606 |
0.615 |
| CBX7 |
O95931
|
chromobox 7
|
Epigenetic regulator
|
0.69 |
0.595 |
0.615 |
| CARD11 |
Q9BXL7
|
caspase recruitment domain family member 11
|
|
1.00 |
0.582 |
0.615 |
| LOC390714 |
|
immunoglobulin heavy chain variable region
|
|
|
0.617 |
0.615 |
| LOC105379528 |
|
uncharacterized LOC105379528
|
|
|
0.617 |
0.615 |
| ABL2 |
P42684
|
ABL proto-oncogene 2, non-receptor tyrosine kinase
|
Kinase
|
3.6E-07 |
0.619 |
0.654 |
| EBF1 |
Q9UH73
|
EBF transcription factor 1
|
|
1.00 |
0.584 |
0.654 |
| FLT3 |
P36888
|
fms related receptor tyrosine kinase 3
|
Kinase
|
0.61 |
0.462 |
0.654 |
| IGH |
|
immunoglobulin heavy locus
|
|
|
0.473 |
0.654 |
| LMO2 |
P25791
|
LIM domain only 2
|
|
0.16 |
0.585 |
0.654 |
| PAX5 |
Q02548
|
paired box 5
|
|
1.00 |
0.487 |
0.654 |